Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Depreciation and Depletion (2022 - 2025)

Historic Depreciation and Depletion for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $116663.5.

  • InflaRx's Depreciation and Depletion fell 467.97% to $116663.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $484877.4, marking a year-over-year decrease of 1224.54%. This contributed to the annual value of $525057.4 for FY2024, which is 1405.14% down from last year.
  • InflaRx's Depreciation and Depletion amounted to $116663.5 in Q3 2025, which was down 467.97% from $130175.4 recorded in Q2 2025.
  • Over the past 5 years, InflaRx's Depreciation and Depletion peaked at $172077.9 during Q1 2022, and registered a low of $116663.5 during Q3 2025.
  • Its 4-year average for Depreciation and Depletion is $142347.9, with a median of $148673.1 in 2022.
  • As far as peak fluctuations go, InflaRx's Depreciation and Depletion soared by 171.78% in 2023, and later tumbled by 1906.8% in 2024.
  • InflaRx's Depreciation and Depletion (Quarter) stood at $151276.1 in 2022, then decreased by 3.6% to $145824.3 in 2023, then decreased by 18.85% to $118333.0 in 2024, then fell by 1.41% to $116663.5 in 2025.
  • Its last three reported values are $116663.5 in Q3 2025, $130175.4 for Q2 2025, and $119705.5 during Q1 2025.